Page last updated: 2024-08-23

pravastatin and Abetalipoproteinemia

pravastatin has been researched along with Abetalipoproteinemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ehrenborg, E; Karpe, F; Ledmyr, H; Lithell, H; MacFarlane, PW; McMahon, AD; Neville, M; Nielsen, LB; Packard, CJ	1

Trials

1 trial(s) available for pravastatin and Abetalipoproteinemia

Article	Year
The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease. Circulation, 2004, May-18, Volume: 109, Issue:19 Topics: Abetalipoproteinemia; Anticholesteremic Agents; Biopsy; Carrier Proteins; Case-Control Studies; Cholesterol, LDL; Codon; Cohort Studies; Coronary Disease; Disease Susceptibility; Double-Blind Method; Genotype; Haplotypes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipoproteins; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Myocardium; Polymorphism, Genetic; Pravastatin; Promoter Regions, Genetic; Prospective Studies; Risk; RNA, Messenger; Scotland; Sweden	2004

Article

Year

The microsomal triglyceride transfer protein gene-493T variant lowers cholesterol but increases the risk of coronary heart disease.

Circulation, 2004, May-18, Volume: 109, Issue:19

Topics: Abetalipoproteinemia; Anticholesteremic Agents; Biopsy; Carrier Proteins; Case-Control Studies; Cholesterol, LDL; Codon; Cohort Studies; Coronary Disease; Disease Susceptibility; Double-Blind Method; Genotype; Haplotypes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Lipoproteins; Longitudinal Studies; Male; Middle Aged; Myocardial Infarction; Myocardium; Polymorphism, Genetic; Pravastatin; Promoter Regions, Genetic; Prospective Studies; Risk; RNA, Messenger; Scotland; Sweden

2004